Sale!

PHENYLBUTAZONE

$70.00

Description

PHENYLBUTAZONE (200mg/ml) (also known as bute) is a non-steroidal anti-inflammatory drug.  It also has analgesic (pain relieving) and antipyretic (fever-reducing) effects and is indicated for the treatment of a wide range of musculoskeletal disorders, including muscular sprain and strain, tendonitis, muscular overuse (including both muscular damage and strain/damage of the tendons attaching muscles to bone), arthritic conditions and acute joint injury/strain/sprain .https://bodaxvet.com/

PHENYLBUTAZONE (200mg/ml) (also known as bute) is a non-steroidal anti-inflammatory drug.  It also has analgesic (pain relieving) and antipyretic (fever-reducing) effects and is indicated for the treatment of a wide range of musculoskeletal disorders, including muscular sprain and strain, tendonitis, muscular overuse (including both muscular damage and strain/damage of the tendons attaching muscles to bone), arthritic conditions and acute joint injury/strain/sprain. phenylbutazone phenylbutazone phenylbutazone

For:  Horses

Indications:  For relief of inflammatory conditions associated with the musculoskeletal system in horses.  Controls pain from injuries, infections, laminitis or virtually any other source of pain.

The analgesic effects are related mainly to the compound’s anti-inflammatory properties

Active ingredient:  Contains 200 mg phenylbutazone, 1.5% benzyl alcohol and purified water per ml.

100 ml Vials, 200 Mg/ml (1g/5ml)

Dosage and Administration: Intravenously (IV) ONLY.  1 to 2g per 1,000 lbs of body weight (5-10 ml/1,000 lbs) daily. should be given slowly and with care.  Limit intravenous (IV) administration to a maximum of 5 successive days, which may be followed by oral phenylbutazone dosage forms.

Guidelines:

1.  Use a relatively high dose of for the first 48 hours, then reduce gradually to a maintenance dose. Maintain lowest dose capable of producing desired clinical response.

2.  Response to P therapy is prompt, usually occurring within 24 hours.  If no significant clinical response is evident after 5 days, re-evaluate diagnosis and therapeutic approach.

3.  In animals is largely metabolized in 8 hours.  It is recommended that one third of the daily dose be administered at 8 hour intervals.  Reduce dosage as symptoms regress.  In some cases, treatment may be given only when symptoms appear with no need for continuous medication.  If long-term therapy is planned, oral administration is therefore suggested.

4.  Many chronic conditions will respond to  therapy, but discontinued treatment may result in recurrence of sympto

Reviews

There are no reviews yet.

Be the first to review “PHENYLBUTAZONE”

Your email address will not be published. Required fields are marked *